Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Multisensory neuromodulation to improve visual field loss after stroke

Official title: Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease

Run by Istituto Auxologico Italiano · NCT07358832 · Data updated 2026-11-12

This will try combining audio-visual training with noninvasive brain stimulation (tDCS) to help people within three months of stroke who have homonymous hemianopsia improve their visual field and visual scanning.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment48 (estimated)
SponsorIstituto Auxologico Italiano
Academic / other
Locations1 site (Milan, Lombardy)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedFebruary 28, 2028
Study endsJanuary 31, 2029
Registry record updatedJanuary 22, 2026
Trial IDNCT07358832 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people within three months of an acquired brain injury with neuro‑ophthalmologically confirmed homonymous hemianopsia who do not have hemispatial neglect, conjugate eye‑movement disorders, other major neurological disease, or contraindications to tDCS (for example, epilepsy, implanted metallic/electronic devices, or pregnancy).

Probably not a fit

Patients with hemispatial neglect, disorders of conjugate eye movements, dementia or other major neurological disorders, chronic visual field loss beyond the subacute window, or contraindications to brain stimulation are unlikely to be eligible or to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The protocol enrolls people in the subacute stage (within 3 months) after an acquired brain injury who have homonymous visual field defects. Participants receive audio-visual training—eye movement exercises paired with synchronized visual and auditory cues—while low‑intensity transcranial direct current stimulation (tDCS) is applied to the lesioned visual cortex to promote plasticity. The approach aims to speed and stabilize functional gains in scanning and daily tasks and potentially restore portions of the lost visual field, addressing a window earlier than most prior work. The study excludes participants with hemispatial neglect, disorders of conjugate eye movements, other major neurological disease, or contraindications to brain stimulation and is conducted at Istituto Auxologico Italiano in Milan.

Why it matters

Potential benefit: If successful, the combined AVT plus tDCS approach could speed recovery and expand visual fields after stroke, improving reading, navigation, independence, and mood.

How similar studies have gone: Early studies, mostly in chronic patients, suggest that pairing tDCS with audio‑visual training can speed and stabilize improvements, but evidence in the subacute stage is limited and still emerging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Presence of subacute acquired brain injury (\< 3 months) with HVFD according to Neurophthalmological evaluation

Exclusion Criteria:

* Presence of hemispatial neglect (indexed by pathological asymmetries on paper-and-pencil tests)
* Disorders of conjugated eye movements
* Other neurological disorders (e.g., dementia)
* Exclusion criteria for brain stimulation (i.e., epilepsy or family history of epilepsy; implanted electrodes, stimulators, pacemakers, infusion pumps, or any implanted metal device; pregnancy)

Where it's running

  • Istituto Auxologico Italiano IRCCS
    Milan, Lombardy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.